Among four finalists in Harvard University’s Acceleration Challenge, a home health tech company—the only home health company on the list—has made the cut.
Medalogix was recognized by the challenge for its Bridge solution; a technology that facilitates end of life care conversations with patients who would benefit from hospice care.
The challenge received applications from close to 500 different health care solutions and recognized the top four finalists with cash prices from Harvard Business School, the administrator of the challenge.
In addition to the prize, Medalogix will be the subject of an upcoming Harvard Business review case study, and will have the opportunity to compete a year from now for the ultimate prize of $50,000.
“Being chosen as one of the more impactful healthcare innovations by such a prestigious institution like Harvard is a great compliment to us and validating to our mission,” said Dan Hogan, Medalogix founder and CEO. “For years we’ve been working with our heads down to innovate and build meaningful technology that improves patient care. Harvard’s Health Acceleration Challenge is a big stage that will give us the platform to affect even more patients in the long run. Our team couldn’t be more thrilled.”
Written by Elizabeth Ecker